Dermatology · Immunobullous Disorders (Pemphigus, Pemphigoid, DH)

In linear IgA bullous dermatosis (LABD) associated with vancomycin intake, the target antigen and the characteristic immunofluorescence pattern are respectively:

  • A Desmoglein-1; IgA in intercellular pattern
  • B Type VII collagen; IgA on the floor of salt-split skin
  • C LAD-1 (97-kDa ectodomain of BP180); linear IgA at the DEJ
  • D Envoplakin; linear IgA at the cell surface
Correct answer: C. LAD-1 (97-kDa ectodomain of BP180); linear IgA at the DEJ

Explanation

Linear IgA bullous dermatosis (LABD) is caused by IgA antibodies against LAD-1, a 97-kDa fragment of the ectodomain of BP180 (also called LABD97). DIF shows linear IgA deposition at the DEJ — the defining immunofluorescence pattern. Vancomycin is the most common drug trigger of LABD. The classic clinical pattern is 'string of pearls' or 'crown of jewels' — new blisters at the periphery of resolving older blisters. Envoplakin is targeted in paraneoplastic pemphigus. Type VII collagen is the target in epidermolysis bullosa acquisita.

Reference: Neena Khanna Illustrated Synopsis of Dermatology & STD, 6th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Immunobullous Disorders (Pemphigus, Pemphigoid, DH) MCQs

See all Immunobullous Disorders (Pemphigus, Pemphigoid, DH) MCQs →